Amass Biosystems
United States · Agri & FoodTech · Pre-seed

Yo-Kai Express Inc.
United States · Agri & FoodTech · Series A
Compatibility /100
55/100
High potentialWhy talk
- Both are based in United States: shared local customers, investors and ecosystem.
- Amass Biosystems likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
- Yo-Kai Express Inc. has raised about $19M — investor introductions are realistic.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
13.8 / 25 pts
Yo-Kai Express Inc. can help Amass Biosystems.
- Amass Biosystems likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
- Amass Biosystems likely needs first paying customers — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer access to its customer base (inferred from public profile).
Market bridge
15.7 / 45 pts
Distant markets.
- Both are based in United States: shared local customers, investors and ecosystem.
Customer potential
8.5 / 10 pts
Strong customer or channel potential.
- Yo-Kai Express Inc. has strong traction in the same sector: More than 250 ramen vending machines deployed (SFO, Tesla factories, Ueno station), according to Taiwan News 2025 — a proven go-to-market and customer relationships Amass Biosystems can learn from or tap.
Sector synergy
7.5 / 10 pts
Same sector: peers.
- Same sector (Agri & FoodTech): peer learning on regulation, pricing and investors; Amass Biosystems works on Plant breeding for bioenergy crops, Yo-Kai Express Inc. on Autonomous restaurant / hot ramen vending machines.
Stage complementarity
9.0 / 10 pts
Strong mentoring / investor-intro potential.
- Yo-Kai Express Inc. has raised about $19M — investor introductions are realistic.
- Yo-Kai Express Inc. (Series A) is well ahead of Amass Biosystems (Pre-seed): mentoring and investor intros.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Market entry”: Needs ↔ offers 25, Market bridge 45, Customer potential 10, Sector synergy 10, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 52/100 — high from 50, medium from 36.